| 000 | 01572 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250512075558.0 | ||
| 264 | 0 | _c19850822 | |
| 008 | 198508s 0 0 eng d | ||
| 022 | _a0277-5379 | ||
| 024 | 7 |
_a10.1016/0277-5379(85)90035-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOfferman, J J | |
| 245 | 0 | 0 |
_aNephrotoxicity of 1,1-diaminomethylcyclohexane sulphato platinum II (spiroplatin; TNO-6). _h[electronic resource] |
| 260 |
_bEuropean journal of cancer & clinical oncology _cApr 1985 |
||
| 300 |
_a447-51 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAcetylglucosaminidase _xurine |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 | _aDrug Evaluation |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlomerular Filtration Rate _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKidney _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasms _xphysiopathology |
| 650 | 0 | 4 |
_aOrganoplatinum Compounds _xadverse effects |
| 650 | 0 | 4 |
_aRenal Circulation _xdrug effects |
| 650 | 0 | 4 |
_abeta 2-Microglobulin _xurine |
| 700 | 1 | _aMeijer, S | |
| 700 | 1 | _aMulder, N H | |
| 700 | 1 | _aSleijfer, D T | |
| 700 | 1 | _aBijster, P | |
| 700 | 1 | _aHellendoorn, H B | |
| 700 | 1 | _aDonker, A J | |
| 700 | 1 | _avan der Hem, G K | |
| 773 | 0 |
_tEuropean journal of cancer & clinical oncology _gvol. 21 _gno. 4 _gp. 447-51 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0277-5379(85)90035-5 _zAvailable from publisher's website |
| 999 |
_c3897050 _d3897050 |
||